- Home
- ARMP vs OM Comparison
ARMP vs OM Comparison
Compare ARMP & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- OM
- Stock Information
- Founded
- ARMP N/A
- OM 2003
- Country
- ARMP United States
- OM United States
- Employees
- ARMP N/A
- OM N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ARMP Health Care
- OM Health Care
- Exchange
- ARMP Nasdaq
- OM Nasdaq
- Market Cap
- ARMP 52.1M
- OM 50.5M
- IPO Year
- ARMP N/A
- OM 2020
- Fundamental
- Price
- ARMP $1.23
- OM $11.01
- Analyst Decision
- ARMP Strong Buy
- OM Buy
- Analyst Count
- ARMP 1
- OM 2
- Target Price
- ARMP $7.00
- OM $45.00
- AVG Volume (30 Days)
- ARMP 30.3K
- OM 141.8K
- Earning Date
- ARMP 05-06-2025
- OM 05-07-2025
- Dividend Yield
- ARMP N/A
- OM N/A
- EPS Growth
- ARMP N/A
- OM N/A
- EPS
- ARMP N/A
- OM N/A
- Revenue
- ARMP $5,174,000.00
- OM $113,689,000.00
- Revenue This Year
- ARMP $8.43
- OM $8.98
- Revenue Next Year
- ARMP N/A
- OM $12.74
- P/E Ratio
- ARMP N/A
- OM N/A
- Revenue Growth
- ARMP 14.24
- OM N/A
- 52 Week Low
- ARMP $0.90
- OM $5.85
- 52 Week High
- ARMP $3.45
- OM $78.30
- Technical
- Relative Strength Index (RSI)
- ARMP 39.22
- OM 52.11
- Support Level
- ARMP $1.11
- OM $10.30
- Resistance Level
- ARMP $1.30
- OM $11.65
- Average True Range (ATR)
- ARMP 0.14
- OM 1.20
- MACD
- ARMP 0.01
- OM 0.08
- Stochastic Oscillator
- ARMP 42.86
- OM 65.42
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.